Another potential implication is a stronger dollar, which would further hurt S&P 500 earnings because the companies get 28% ...

Goldman Sachs downgraded Dynavax (DVAX) to Sell from Neutral with a price target of $12, down from $15. The evolving competitive landscape in ...

Goldman Sachs downgraded Regenxbio (RGNX) to Neutral from Buy with a price target of $14, down from $38. The firm has questions over the ...

DeepSeek has enabled investors to see the potential of Chinese technology stocks. Since February, several foreign-funded ...

Goldman Sachs, Wells Fargo, Citigroup, Bank of America, Morgan Stanley and JPMorgan - which left the alliance over the last ...

Employees’ privileged access to its own funds show a widening compensation gap on Wall Street. Marc Rubinstein is a former ...

Finding stocks with the potential to double in just three years is no easy feat, even in this bull market. Plenty of ...

The unemployment rate, which is derived from a separate survey, declined to 4% from 4.1% the prior month. Economists expected ...

The U.S. junk market, by contrast, has a “largely manageable” volume of debt coming due in the next three years.

We recently compiled a list of the 10 Best Rebound Stocks To Invest In Now. In this article, we are going to take a look at ...

Chinese investors are rushing into AI-related stocks, betting the artificial intelligence advance of home-grown startup DeepSeek will lead to a boom in the sector and give the initiative to China in ...

The largest impact will be on Ford's Lincoln Nautilus and General Motors’ Buick Envision, which accounted for 95% of ...